SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News

Doctor Killed in Double Stabbing; Thyroid Pill Recall Upgraded; HHS Nominee Advances

Health news and commentary gathered by MedPage Today staff

FDA Approves Efsitora Weekly Insulin for Type 2 Diabetes

— Approval marks the second once-weekly basal insulin for this population

Short Steroid Bursts Tied to Serious Adverse Events in Diabetes

— Analysis found increased pneumonia, heart failure, and bleeding risks

FDA Warns Pharmacy About Illegal GLP-1 Compounding

Agency's letter flagged issues with copycat manufacturing and sterility

2 Hot Dogs or 1 Large Cookie? A Study of Risks by Amount of Ultraprocessed Food

— Mounting observational evidence links ultraprocessed food with heart disease, cancer, death

Stem Cell Infusion Cut Fractures; Testosterone for Menopause; BMD and Cognition

— News and commentary from the endocrinology world

Todays Updates

ASTRO: American Society for Radiation Oncology

Todays Updates

ASTRO: American Society for Radiation Oncology

Latest News

Health news and commentary gathered by MedPage Today staff

— Approval marks the second once-weekly basal insulin for this population

— Analysis found increased pneumonia, heart failure, and bleeding risks

Agency's letter flagged issues with copycat manufacturing and sterility

— Mounting observational evidence links ultraprocessed food with heart disease, cancer, death

— News and commentary from the endocrinology world

News All Time

About a Quarter of Those Who Stop Wegovy Start Again

Real-world Danish data showed steady discontinuation among first-time users

GLP-1 Drugs Tied to Gallbladder and Biliary Risks in Youth

Real-world study identifies safety signal in young people with overweight or obesity

Mounjaro's Label Expands; Type 1 Diabetes on the Rise; Testosterone and Afib

News and commentary from the endocrinology world

High Fertility Costs Push Americans Abroad for IVF Treatment

Infertility affects nearly 7 million in the U.S.

Pesticide Found in Supplement; Brain-Eating Amoeba Kills Teen; B12 and Birth Defects

Health news and commentary gathered by MedPage Today staff

ADA Says Booted Meeting Attendees Violated Code of Conduct

Expelled researchers unhappy with conclusion of organization's review

Off-Label GLP-1 Use Skyrockets in Young Kids

Weight-loss formulations are only approved for kids 12 years and older

Endometriosis Can Elude Diagnosis for Years. What to Know About New Ways to Find It.

New tests available abroad are raising hope among doctors and patients

New GLP-1 Hair Loss Insights; Wegovy in Kids; Are Fitness Trackers Lying to Users?

News and commentary from the endocrinology world

Preschoolers With Cystic Fibrosis Get Close to Normal on Alyftrek

TIMBERLINE study shows good safety and sweat chloride reductions with triple combo CFTR modulator

Menopausal Hormone Therapy May Ease Severe Mood Symptoms

Therapy also associated with better sleep scores in non-controlled study

The CDC Division I Spent 15 Years Building Is in Peril

Cuts to the Division of Nutrition, Physical Activity, and Obesity will not make America healthy

The Market Forces Quietly Adding Thousands to Patient Bills

A look at a shifting industry

Preserving Muscle During GLP-1 Weight Loss

Experts advise tracking body composition, boosting protein, and resistance training

Early T1D Screening Guide; FDA Clears Mint Patch Pump; GLP-1s and Fertility

News and commentary from the endocrinology world

ADA Boycott Follows Meeting Scandal; Lawsuits Fly in Residency Application Space

MedPage Today reporters offer further insights into recently covered topics

Recommended News For You

Scream, It's Good for You; Release the Cancer Pigeons; Talk of Chemo Rationing

Patients With Early-Onset Cancer Unaware of Infertility Risk

Diagnosis of Mass Confined to the Kidney: Is It RCC or TCC?

mRNA-based COVID vaccines generate improved responses to immunotherapy

Marstacimab Gets FDA Nod for Hemophilia A or B Without Inhibitors

FDA Bans Red Dye No. 3 From Foods, Ingested Drugs

C/EBP? works in tandem with MYB to sustain AML cells' oncogenic program.

Recommended Articles For You

From Birthmarks to Tumors: The Science Behind Infantile Hemangioma  

A Revolutionary Guide to Calculating Absolute Neutrophil Counts 

Immune Surveillance Screening for Early Cancer Risk Detection 

Liquid Biopsies Unveiling the Future of Precision Cancer Management by 2025 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer After Weight Loss; How Older Adults Use the Healthcare System.

2.

Mortality up for children with leukemia from lowest SES neighborhoods

3.

Response Duration After Stopping Enfortumab Vedotin in Bladder Cancer

4.

Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC

5.

Trial Supports Ivonescimab and Chemo for NSCLC Survival

1.

Emerging Therapies Through Personalized Tumor Ecosystem Remodeling

2.

Clinical Guidelines for Neutropenic Complication Monitoring

3.

Novel Antibody Conjugates in Cancer: Mechanisms, Clinical Evidence, and Therapeutic Implications

4.

Platelet Dysfunction During Severe Systemic Inflammation: Mechanisms, Clinical Implications, and Emerging Therapeutic Approaches

5.

What is Mullerian and How Does it Affect Your Health

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

1.

An In-Depth Look At The Signs And Symptoms Of Lymphoma

2.

Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals

3.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV

4.

Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC

5.

CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot